Preferred Label : irRECIST Progressive Disease;
NCIt related terms : irPD;
NCIt definition : A minimum 20% increase and minimum 5 mm absolute increase in total measured tumor
burden compared to nadir, or irPD for non-target or new non-measurable lesions. Confirmation
of progression is recommended minimum 4 weeks after the first irPD assessment.;
Alternative definition : CDISC: Increase in tumor burden greater than or equal to 25% relative to nadir (minimum
recorded tumor burden). (irRECIST);
NCI Metathesaurus CUI : CL538453;
Origin ID : C140319;
UMLS CUI : C4554245;
Semantic type(s)
- concept_is_in_subset
